Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00214123
Status:
COMPLETED
Last Update Posted:
2019-12-13
First Post:
2005-09-13
Brief Title:
Hypofractionated Radiotherapy for Lung Cancer
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to pilot reducing the duration of radiation treatment for lung cancer patients from 6 to 5 weeks using tomotherapy Specific patient doses will be based on tumor volume being treated Modeling has shown that increased biologically effective dose BED to tumors can be achieved by shortening the radiation delivery schedule and increasing the dose per fraction This requires decreasing the total dose to hold lung toxicity constant at each dose per fraction level This is a major paradigm shift in the treatment in this disease and is projected to result in significant improvements in patient outcome as well as a substantial cost savings
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2011-00868 | REGISTRY | NCI Trial ID | None |
| A533300 | OTHER | None | None |
| SMPHHUMAN ONCOLOGYHUMAN ONCO | OTHER | None | None |